The INSTI® Multiplex HIV-1/2 Syphilis Antibody Test delivers highly accurate results in just 60 seconds with a single sample—the fastest dual HIV/syphilis rapid test available. Now included in the ...

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that ...

(RTTNews) - Qiagen N.V. (QGEN) announced Monday that the U.S. Food and Drug Administration or FDA has granted Emergency Use Authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test. The ...

SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today ...

Aug. 15 (UPI) --The U.S. Food and Drug Administration has issued an Emergency Use Authorization for the first multiplex test for the Zika virus and three other viruses. The FDA made the authorization ...

Examination of patients’ responses to direct-to-consumer genetic susceptibility tests is needed to inform clinical practice. This study examined patients’ recall and interpretation of, and responses ...

Fast and easy-to-use respiratory PCR test comes onto market as flu season gains pace in Northern Hemisphere CE-IVD marking in Europe granted for NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test, has also ...